• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Modality
o Market segments
o Comparison by Modality
o Veno-venous – Market size and forecast 2020-2025
o Veno-arterial – Market size and forecast 2020-2025
o Market opportunity by Modality
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o ALung Technologies Inc.
o Eurosets Srl
o Fresenius Medical Care AG and Co. KGaA
o Getinge AB
o LivaNova Plc
o Medtronic Plc
o MicroPort Scientific Corp.
o Nipro Corp.
o OriGen Biomedical Inc.
o Terumo Corp.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Modality – Market share 2020-2025 (%)
• 22: Comparison by Modality
• 23: Veno-venous – Market size and forecast 2020-2025 ($ million)
• 24: Veno-venous – Year-over-year growth 2020-2025 (%)
• 25: Veno-arterial – Market size and forecast 2020-2025 ($ million)
• 26: Veno-arterial – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Modality
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2020-2025 ($ million)
• 32: North America – Year-over-year growth 2020-2025 (%)
• 33: Europe – Market size and forecast 2020-2025 ($ million)
• 34: Europe – Year-over-year growth 2020-2025 (%)
• 35: Asia – Market size and forecast 2020-2025 ($ million)
• 36: Asia – Year-over-year growth 2020-2025 (%)
• 37: ROW – Market size and forecast 2020-2025 ($ million)
• 38: ROW – Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ million)
• 41: Impact of drivers and challenges
• 42: Vendor landscape
• 43: Landscape disruption
• 44: Industry risks
• 45: Vendors covered
• 46: Market positioning of vendors
• 47: ALung Technologies Inc. – Overview
• 48: ALung Technologies Inc. – Product and service
• 49: ALung Technologies Inc. – Key offerings
• 50: ALung Technologies Inc. – Key customers
• 51: ALung Technologies Inc. – Segment focus
• 52: Eurosets Srl – Overview
• 53: Eurosets Srl – Product and service
• 54: Eurosets Srl – Key offerings
• 55: Eurosets Srl – Key customers
• 56: Eurosets Srl – Segment focus
• 57: Fresenius Medical Care AG and Co. KGaA – Overview
• 58: Fresenius Medical Care AG and Co. KGaA – Business segments
• 59: Fresenius Medical Care AG and Co. KGaA – Key offerings
• 60: Fresenius Medical Care AG and Co. KGaA – Key customers
• 61: Fresenius Medical Care AG and Co. KGaA – Segment focus
• 62: Getinge AB – Overview
• 63: Getinge AB – Business segments
• 64: Getinge AB – Key offerings
• 65: Getinge AB – Key customers
• 66: Getinge AB – Segment focus
• 67: LivaNova Plc – Overview
• 68: LivaNova Plc – Business segments
• 69: LivaNova Plc – Key offerings
• 70: LivaNova Plc – Key customers
• 71: LivaNova Plc – Segment focus
• 72: Medtronic Plc – Overview
• 73: Medtronic Plc – Business segments
• 74: Medtronic Plc – Key offerings
• 75: Medtronic Plc – Key customers
• 76: Medtronic Plc – Segment focus
• 77: MicroPort Scientific Corp. – Overview
• 78: MicroPort Scientific Corp. – Business segments
• 79: MicroPort Scientific Corp. – Key offerings
• 80: MicroPort Scientific Corp. – Key customers
• 81: MicroPort Scientific Corp. – Segment focus
• 82: Nipro Corp. – Overview
• 83: Nipro Corp. – Business segments
• 84: Nipro Corp. – Key offerings
• 85: Nipro Corp. – Key customers
• 86: Nipro Corp. – Segment focus
• 87: OriGen Biomedical Inc. – Overview
• 88: OriGen Biomedical Inc. – Product and service
• 89: OriGen Biomedical Inc. – Key offerings
• 90: OriGen Biomedical Inc. – Key customers
• 91: OriGen Biomedical Inc. – Segment focus
• 92: Terumo Corp. – Overview
• 93: Terumo Corp. – Business segments
• 94: Terumo Corp. – Key offerings
• 95: Terumo Corp. – Key customers
• 96: Terumo Corp. – Segment focus
• 97: Currency conversion rates for US$
• 98: Research Methodology
• 99: Validation techniques employed for market sizing
• 100: Information sources
• 101: List of abbreviations
【掲載企業】
ALung Technologies Inc., Eurosets Srl, Fresenius Medical Care AG and Co. KGaA, Getinge AB, LivaNova Plc, Medtronic Plc, MicroPort Scientific Corp., Nipro Corp., OriGen Biomedical Inc., Terumo Corp.